BioNTech SE - ADR vs The Vita Coco Company Inc — how do they compare? BioNTech SE - ADR trades at $89.89 (market cap $22.78B), while The Vita Coco Company Inc trades at $74.45 (market cap $4.26B). The key difference: BioNTech SE - ADR is far larger — about 5.3× The Vita Coco Company Inc's market cap, and The Vita Coco Company Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | COCO | |
|---|---|---|
Market Cap | $22.78B | $4.26B |
Sector | Health | Technology |
52-Week High | $119.34 | $84.02 |
52-Week Low | $83.89 | $32.30 |
Enterprise Value | $6.45B | $4.07B |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →The Vita Coco Company is a leading functional beverage brand specializing in coconut water. Its portfolio includes its flagship Vita Coco brand, clean energy drinks, and sustainable enhanced water products.
Read more on COCO →